Corneal manifestations of the systemic mucopolysaccharidoses.
Newer biochemical understanding of the mucopolysaccharidoses now allows a better classification of these diseases. The dermatan and keratan sulfate-storing diseases have corneal clouding. The heparan sulfate-storing diseases have retinal changes and usually central nervous system manifestations.
D002648:Child; D003316:Corneal Diseases / Q000209:etiology* / Q000378:metabolism / Q000473:pathology; D003871:Dermatan Sulfate / Q000378:metabolism; D006025:Glycosaminoglycans / Q000378:metabolism*; D006497:Heparan Sulfate / Q000378:metabolism; D006801:Humans; D007632:Keratan Sulfate / Q000378:metabolism; D009083:Mucopolysaccharidoses / Q000145:classification / Q000150:complications* / Q000473:pathology; D013577:Syndrome
D003871:Dermatan Sulfate; D006025:Glycosaminoglycans; D006497:Heparan Sulfate; D007632:Keratan Sulfate